There’s nothing like spending $74 billion on an acquisition to get shareholders’ attention. That’s what Bristol-Myers Squibb Co. (NYSE: BMY) found out Thursday morning following the announcement of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback